ArticleBritish journal of cancer2023

Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.

Zsuzsanna Valko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.